image
Industrials - Integrated Freight & Logistics - NASDAQ - US
$ 7.56
-7.8 %
$ 379 M
Market Cap
-8.04
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Aug, 10, 2025.

The intrinsic value of one CYRX stock under the worst case scenario is HIDDEN Compared to the current market price of 7.56 USD, Cryoport, Inc. is HIDDEN

This DCF valuation model was last updated on Aug, 10, 2025.

The intrinsic value of one CYRX stock under the base case scenario is HIDDEN Compared to the current market price of 7.56 USD, Cryoport, Inc. is HIDDEN

This DCF valuation model was last updated on Aug, 10, 2025.

The intrinsic value of one CYRX stock under the best case scenario is HIDDEN Compared to the current market price of 7.56 USD, Cryoport, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CYRX

image
$8.5$8.5$8.0$8.0$7.5$7.5$7.0$7.0$6.5$6.5$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '2515 Jul15 JulAug '25Aug '25
FINANCIALS
228 M REVENUE
-2.09%
-131 M OPERATING INCOME
-13.64%
-115 M NET INCOME
-15.23%
-16.3 M OPERATING CASH FLOW
-2056.27%
177 M INVESTING CASH FLOW
390.54%
-162 M FINANCING CASH FLOW
-578.76%
41 M REVENUE
-31.06%
-9.48 M OPERATING INCOME
31.92%
-12 M NET INCOME
35.85%
-4.34 M OPERATING CASH FLOW
20.77%
5.92 M INVESTING CASH FLOW
70.22%
-189 K FINANCING CASH FLOW
-9.39%
Balance Sheet Cryoport, Inc.
image
Current Assets 342 M
Cash & Short-Term Investments 262 M
Receivables 45.8 M
Other Current Assets 34 M
Non-Current Assets 362 M
Long-Term Investments 0
PP&E 136 M
Other Non-Current Assets 226 M
37.21 %6.51 %4.84 %19.34 %32.11 %Total Assets$703.5m
Current Liabilities 64.6 M
Accounts Payable 27.2 M
Short-Term Debt 20.3 M
Other Current Liabilities 17 M
Non-Current Liabilities 237 M
Long-Term Debt 230 M
Other Non-Current Liabilities 6.68 M
9.02 %6.75 %5.64 %76.38 %Total Liabilities$301.6m
EFFICIENCY
Earnings Waterfall Cryoport, Inc.
image
Revenue 228 M
Cost Of Revenue 129 M
Gross Profit 99.6 M
Operating Expenses 150 M
Operating Income -131 M
Other Expenses -16.1 M
Net Income -115 M
250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)228m(129m)100m(150m)(131m)16m(115m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
43.62% GROSS MARGIN
43.62%
-57.30% OPERATING MARGIN
-57.30%
-50.25% NET MARGIN
-50.25%
-28.55% ROE
-28.55%
-16.31% ROA
-16.31%
-20.07% ROIC
-20.07%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Cryoport, Inc.
image
00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)(25m)(25m)(30m)(30m)(35m)(35m)(40m)(40m)(45m)(45m)(50m)(50m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -115 M
Depreciation & Amortization 30.8 M
Capital Expenditures -17.3 M
Stock-Based Compensation 19.7 M
Change in Working Capital -8.61 M
Others 46.4 M
Free Cash Flow -33.6 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Cryoport, Inc.
image
Wall Street analysts predict an average 1-year price target for CYRX of $10.7 , with forecasts ranging from a low of $10 to a high of $11 .
CYRX Lowest Price Target Wall Street Target
10 USD 32.28%
CYRX Average Price Target Wall Street Target
10.7 USD 41.09%
CYRX Highest Price Target Wall Street Target
11 USD 45.50%
Price
Max Price Target
Min Price Target
Average Price Target
11111010998877665544Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26Aug '26Aug '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 9
6. Ownership
Insider Ownership Cryoport, Inc.
image
Sold
0-3 MONTHS
3.34 M USD 4
3-6 MONTHS
132 K USD 4
6-9 MONTHS
1.55 M USD 3
9-12 MONTHS
26.9 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy? CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 1 week ago
CryoPort, Inc. (CYRX) Just Flashed Golden Cross Signal: Do You Buy? CryoPort, Inc. (CYRX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CYRX's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross. zacks.com - 2 weeks ago
Cryoport to Report Second Quarter 2025 Financial Results on August 5, 2025 NASHVILLE, Tenn. , July 22, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the second quarter ended June 30, 2025 on Tuesday, August 5, 2025 after U.S. markets close. prnewswire.com - 2 weeks ago
Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers New SC vapor shipper series improves reliability through extended hold times and patented impact-absorbing and Vapor Shield Technology NASHVILLE, Tenn. , July 8, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' new vapor shippers, the SC 4/2V and SC 4/3V, offering medical and animal health professionals, laboratories, researchers, hospitals and clinics, pharmaceutical companies, and others dramatically improved safety and reliability for transporting and preserving sensitive biological materials at cryogenic temperatures. prnewswire.com - 1 month ago
What Makes CryoPort, Inc. (CYRX) a Strong Momentum Stock: Buy Now? Does CryoPort, Inc. (CYRX) have what it takes to be a top stock pick for momentum investors? Let's find out. zacks.com - 1 month ago
CEO Jerrell Shelton Sells Some Shares of Cryoport (CYRX) According to the SEC Form 4 filing on June 26, 2025, Jerrell Shelton, President and CEO, exercised $5 per share options on 16,344 shares of Cryoport (CYRX 4.18%) and proceeded to sell them at $7.0586 per share (on average) on June 24, 2025, for a total sale price of $115,365. fool.com - 1 month ago
CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know CryoPort (CYRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com - 1 month ago
Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group NASHVILLE, Tenn. , June 12, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leader in temperature-controlled supply chain solutions for the Life Sciences, with a focus on regenerative medicine, today announced the completion of the previously disclosed divestiture of its specialty courier business, CRYOPDP, to DHL Group ("DHL"), one of the world's leading logistics providers, in a transaction that includes cash payments of approximately $200 million to Cryoport. prnewswire.com - 1 month ago
Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade The average of price targets set by Wall Street analysts indicates a potential upside of 81.4% in CryoPort (CYRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com - 2 months ago
Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect? The mean of analysts' price targets for CryoPort (CYRX) points to a 54.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. zacks.com - 2 months ago
Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript Cryoport, Inc. (NASDAQ:CYRX ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Kyle Crews - UBS Richard Baldry - ROTH Capital David Larsen - BTIG Subbu Nambi - Guggenheim Securities Matt Stanton - Jefferies Anna Snopkowski - KeyBanc Operator Good afternoon, and welcome to Cryoport's First Quarter 2025 Earnings Call. All participants will start in a listen-only mode. seekingalpha.com - 3 months ago
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.43 per share a year ago. zacks.com - 3 months ago
8. Profile Summary

Cryoport, Inc. CYRX

image
COUNTRY US
INDUSTRY Integrated Freight & Logistics
MARKET CAP $ 379 M
Dividend Yield 0.00%
Description Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
Contact 112 Westwood Place, Brentwood, TN, 37027 https://www.cryoport.com
IPO Date Aug. 22, 2005
Employees 1090
Officers Mr. Edward J. Zecchini Senior Vice President and Chief Digital & Technology Officer Mr. Tony Ippolito Vice President, General Counsel & Corporate Secretary Mr. Jerrell W. Shelton Chairman, President & Chief Executive Officer Mr. Phil Wilson Chief Operating Officer of Cryoport Systems, LLC Ms. Kylie A. Crowe Vice President of Global Human Resources & Organizational Development Mr. Robert S. Stefanovich MS Senior Vice President, Chief Financial Officer, Treasurer & Chief Administrative Officer Dr. Mark W. Sawicki Ph.D. Senior Vice President & Chief Scientific Officer Mr. Thomas J. Heinzen Vice President of Corporate Development & Investor Relations